Veerhealth Care Limited is proud to announce that the Company have been allotted Labeler Code from US FDA. As per Section 510 of the Federal Food, Drug and Cosmetic, Act (Act), 21 U.S.C. 360: "Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which is a universal product identifier for human drugs. Each listed drug product is assigned a unique 10-digit, 3-segment number. This number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the Labeler Code, is assigned by the US FDA. With the allotment of Labeler Code, now Company will be eligible to expand the business to various customers of the institutional supply industry in US market. With this new avenue of entry in the US market, Company is expecting additional growth in turnover with approximately 10% Profit after Tax from the next financial year.